{
    "response": "To help prevent further damage to your eyes, especially given your diagnoses of primary acute angle-closure glaucoma and senile cataract, there are several lifestyle changes and precautions you can take. These measures are based on evidence from medical literature and tailored to your condition. Here’s what you can do: \n\n1. **Regular Follow-Up Appointments**: It’s crucial to attend regular follow-up visits with your ophthalmologist. These appointments allow for monitoring of your intraocular pressure (IOP) and the progression of your cataract. Gonioscopy and other diagnostic tests will help ensure that your treatment plan remains effective. \n\n2. **Healthy Diet**: While there is no specific diet proven to prevent cataracts or glaucoma, a well-balanced diet rich in fruits and vegetables may be beneficial. Some studies suggest that nutrients like vitamin C, lutein, and zeaxanthin could have a protective effect against cataracts. \n\n3. **Physical Activity**: Engaging in regular physical activity may help reduce the risk of cataract progression. Avoid prolonged periods of inactivity, as this has been associated with an increased risk of cataracts. \n\n4. **Smoking Cessation**: If you smoke, quitting is essential. Smoking is a known risk factor for cataracts and can exacerbate eye health issues. \n\n5. **Medication Management**: If you are on long-term medications, particularly corticosteroids, discuss their use with your doctor, as they can increase the risk of cataracts. Ensure you are using your prescribed eye drops correctly and consistently to manage your glaucoma. \n\n6. **Eye Protection**: Protect your eyes from trauma and excessive UV exposure by wearing sunglasses with UV protection. This can help reduce the risk of further damage. \n\n7. **Monitor Symptoms**: Be vigilant about any changes in your vision, such as increased blurriness, eye pain, or redness. Report these symptoms to your ophthalmologist immediately, as they could indicate a worsening of your condition. \n\nBy incorporating these lifestyle changes and adhering to your treatment plan, you can help manage your eye health and reduce the risk of further damage. Always consult your ophthalmologist for personalized advice and adjustments to your care plan.",
    "context": [
        {
            "id": 0,
            "source": "Cataract in the Adult Eye PPP",
            "content": "## MANAGEMENT\n### Prevention\nPreventive measures that impart even a modest decrease in the risk of cataract could have a large public health impact, given that 24.4 million people over the age of 40 years in the United States are affected by cataract.\nThe role of diet and antioxidant supplements has been studied with mixed conclusions. A 2012 Cochrane Systematic Review of nine randomized controlled trials found no evidence to support high doses of vitamin E, vitamin C, or beta-carotene in preventing development or progression of cataract.\nA more recent systematic review about the role of nutrient supplementation on lens pathology found that vitamin C, beta-carotene, and lutein and zeaxanthin had a protective effect against cataract, but this analysis included observational data.\nThere is currently no level 1 evidence to suggest that high-dose antioxidant supplementation slows cataract progression. There is moderate evidence that a multivitamin/mineral supplement may decrease the risk of cataract.\nSeveral observational studies also demonstrate the potential benefit of a healthy diet in preventing cataract.\nThere is currently insufficient evidence to support a specific diet, but a well-balanced diet rich with fruits and vegetables is a reasonable recommendation based on observational studies. Appendix 3 summarizes studies of nutrition and cataract.\nLong-term increased physical activity and exercise may decrease the risk of cataract. Additionally, long periods of inactivity and prolonged sitting may be associated with cataract progression.\nThe effect of medications on the formation of cataract is difficult to study since the effect of the medication is hard to distinguish from the effect of the disease being treated. Long-term users of inhaled or oral corticosteroids are at higher risk of cataract formation. The use of intranasal corticosteroids, however, is not associated with a significant risk of incident cataract based on two recent systematic reviews.\nThe association between statin use and cataract has been studied extensively with conflicting results.\nPhenothiazines have been associated with anterior subcapsular opacities. Multiple studies show no benefit of aspirin on cataract development or the need for cataract surgery.\nThere is a long list of drugs that may be associated with cataract in prevalence studies, but longitudinal studies are needed to confirm a causative relationship. Patients on medications who are at high risk for cataract formation should be counseled and monitored.\nThe presence of diabetes mellitus, hypertension, obesity, and metabolic syndrome (diabetes, hypertension, obesity, and dyslipidemia) is associated with an increased risk of cataract or cataract surgery in numerous observational studies. Prevention and treatment of these conditions may reduce the risk of cataract.\nSmoking is a risk factor for various types of cataracts, with a dose-response effect seen for nuclear sclerosis. Cessation of smoking reduces the risk of cataract development or progression and cataract surgery, and patients should be counseled to quit smoking.\n## Nonsurgical Management\nThe management of visually significant cataract is primarily surgical. However, there are nonsurgical means for managing the symptoms of cataract before surgery is necessary.\nChanges to glasses and contact lens prescriptions can often be made to account for refractive shifts in the early stages of cataract development. Low-vision devices can maximize remaining vision pending cataract surgery or allow surgery to be deferred in patients at high risk of complications.\nCurrently, no pharmacological treatments are known to eliminate existing cataract or retard its progression. Ophthalmologists should advise patients that, at this time, there is insufficient evidence to support the use of pharmacological treatments for cataract, based on a 2017 Cochrane Systematic Review of N-acetylcarnosine drops.\nPatients who are long-term users of topical ophthalmic, periocular, oral, and inhaled corticosteroids should be informed of the increased risk of cataract development and may wish to discuss alternative treatments with their primary care physician. In limited circumstances, and often as a temporizing measure, the pupil can be dilated to provide better vision around a small central cataract. However, this strategy may worsen glare disability."
        },
        {
            "id": 1,
            "source": "Primary Angle-Closure Disease PPP",
            "content": "## Follow-up Evaluation\nThe recommendations for follow-up evaluations after iridotomy for angle closure apply to ongoing management of PACD and not to visits for other purposes. Following LPI, patients may have an open anterior chamber angle or an anterior chamber angle with a combination of open sectors with areas occluded by PAS. With or without glaucomatous optic neuropathy, patients with a residual open angle or a combination of open angle and some PAS should be followed at appropriate intervals to check for increasing PAS. Special attention should be given to repeat gonioscopy to determine interval changes such as increased extent of PAS or development of secondary angle closure from cataract progression and increased lens thickness. Subsequent follow-up intervals depend on the clinical findings and judgment of the treating ophthalmologist.\nIf IOP remains elevated long term and the patient develops PAC or PACG, then ongoing medical therapy to lower IOP may become necessary. In such a situation, follow-up procedures and intervals would be dictated by the same principles outlined in the Primary Open-Angle Glaucoma PPP. As in primary open-angle glaucoma, adherence to medical therapy may be handicapped when patients run out of medication, due to inadvertent drop wastage or inability to properly instill eyedrops, before they are permitted to refill their prescription. One study found this was more likely for patients who self-administered eyedrop medications when visual acuity was worse than 20/70 in either eye. However, according to a 2010 directive, patients with Medicare insurance may now refill their medication after they have completed at least 70% of the month, or approximately 21 days of therapy.\n## PROVIDER AND SETTING\nThe performance of certain diagnostic procedures (e.g., tonometry, perimetry, pachymetry, anterior segment imaging, optic disc imaging, and photography) may be delegated to appropriately trained and supervised personnel. However, the interpretation of results and medical and surgical management of disease require the medical training, clinical judgment, and experience of the ophthalmologist. Most diagnostic and therapeutic procedures can be undertaken safely on an outpatient basis. Hospitalization may be indicated for intensive treatment of an AACC so that patients can be monitored closely after surgical procedures associated with a high risk of serious short-term postoperative complications. It may also be indicated for patients who have experienced surgical complications or for patients who have special medical or social needs.\n## COUNSELING AND REFERRAL\nIf the diagnosis or management of PACD is in question or is refractory to treatment, consultation with or referral to an ophthalmologist with special training or experience in managing these conditions may be indicated. Patients with substantial visual impairment or blindness may benefit from appropriate vision rehabilitation and social services. More information on vision rehabilitation, including materials for patients, is available at [www.aao.org/smart-sight-low-vision](www.aao.org/smart-sight-low-vision).\n## SOCIOECONOMIC CONSIDERATIONS\nAt the individual patient level, research has demonstrated that glaucomatous vision loss can have a dramatic impact on a patient’s well-being. Patients with glaucoma may struggle with daily activities such as reading, walking, and driving. Performance of these activities deteriorates with worsening of glaucoma severity and when both eyes are affected. Studies have reported that patients with glaucoma are three times more likely to experience falls and six times more likely to be involved in motor vehicle collisions compared with controls. Quality of life is affected for patients with all stages of glaucoma, even those with early disease.\nThe costs of managing a chronic disease like glaucoma can be broken down into direct medical costs, direct nonmedical costs, and indirect costs. Direct costs include costs of visits to eye care providers, ancillary testing, and medical and surgical interventions. One study estimated that nearly $3 billion USD per year is spent on the direct medical costs for all forms of glaucoma. Direct nonmedical"
        },
        {
            "id": 2,
            "source": "Primary Angle-Closure Disease PPP",
            "content": "## HIGHLIGHTED FINDINGS AND RECOMMENDATIONS FOR CARE\nUnderstanding the current disease definition is important in the management of the primary angle-closure disease (PACD) spectrum. Modern classification includes:\n- Primary angle-closure suspect (PACS): ≥180 degrees iridotrabecular contact (ITC), normal intraocular pressure (IOP), and no optic nerve damage\n- Primary angle closure (PAC): ≥180 degrees ITC with peripheral anterior synechiae (PAS) or elevated IOP but no optic neuropathy\n- Primary angle-closure glaucoma (PACG): ≥180 degrees ITC with PAS, elevated IOP, and optic neuropathy\n- Acute angle-closure crisis (AACC): occluded angle with symptomatic high IOP\n- Plateau iris configuration: narrow angle due to an anteriorly positioned ciliary body, with deep central anterior chamber\n- Plateau iris syndrome: narrow angle due to an anteriorly positioned ciliary body, with deep central anterior chamber, and any ITC persisting after patent peripheral iridotomy\nCommon risk factors for PACD include Asian descent, hyperopia, older age, female gender, short axial length, and thick and anteriorly positioned crystalline lens.\nDark-room dynamic gonioscopy should be performed to diagnose PACD and to verify improvement in angle configuration following treatment. Ultrasound biomicroscopy (UBM) and anterior segment optical coherence tomography (AS-OCT) can also aid in the diagnosis of angle closure, but only UBM and dynamic gonioscopy can identify the etiology of plateau iris.\nThe clinical signs and symptoms of AACC include pressure-induced corneal edema (experienced as blurred vision and occasionally as halos around lights), a mid-dilated pupil, vascular congestion (i.e., conjunctival and episcleral), eye pain, headache, and nausea/vomiting.\nPatients experiencing AACC should receive medical treatment, including aqueous suppressants, parasympathomimetics, and osmotic agents, if necessary, to lower the IOP acutely and relieve symptoms. This should be followed by laser iridotomy or iridectomy. After addressing the episode of AACC, it is important to perform laser iridotomy in the fellow eye when indicated.\nLens extraction is an effective treatment for some patients with PAC and PACG."
        }
    ],
    "QuestionID": "2",
    "llm_name": "deepseek-chat",
    "Question": "What lifestyle changes should I make to prevent further damage to my eyes?",
    "clinical_data": {
        "Age": 79.0,
        "Gender": "Female",
        "AdmissionDate": "2024-06-30T00:00:00",
        "DischargeDate": "2024-07-05T00:00:00",
        "AdmissionDiagnosis": "1. Left eye primary acute angle-closure glaucoma; 2. Left eye senile cataract",
        "DischargeDiagnosis": "1. Left eye primary acute angle-closure glaucoma; 2. Left eye senile cataract",
        "ClinicalHistory": "Chief Complaint: Sudden onset of distending pain and blurred vision in the left eye for 4 days.\nHistory of Present Illness: Four days ago, the patient experienced sudden onset of distending pain in the left eye without obvious precipitating factors, accompanied by a rapid decrease in vision. Both distant and near vision were unclear, accompanied by irritative symptoms such as eye redness, photophobia, and tearing, as well as ipsilateral headache and nausea. Denies history of ocular trauma. As symptoms persisted without relief, the patient came to our hospital today for treatment. After relevant examinations in the outpatient clinic, the patient was admitted with a provisional diagnosis of \"1. Left eye primary acute angle-closure glaucoma; 2. Bilateral pseudophakia.\" During the course of the illness, there was no fever or cough. Appetite and sleep were poor, but bowel movements and urination were normal.\nPast Medical History and Surgical/Trauma History: General condition: Usually in general good health. Denies history of chronic diseases such as diabetes mellitus and coronary heart disease; denies history of blood transfusion or trauma. Denies history of infectious diseases such as hepatitis, tuberculosis, bacillary dysentery, and typhoid fever. Immunizations completed on schedule. Denies allergies to sulfonamide drugs, streptomycin, gentamicin, penicillin, cephalosporins, other medications, or any known food allergies.\nOphthalmic Examination: Vod 0.4, Vos 0.1. IOP OD Tn, OS T+2. Right eye: conjunctiva without hyperemia, cornea clear, peripheral anterior chamber shallow, aqueous humor clear, pupil round with a diameter of approximately 3mm, reactive to light (+), lens turbid, fundus visible with retina attached, no obvious hemorrhage or exudation seen. Left eye: conjunctival mixed hyperemia (++), corneal opacity and edema, subepithelial bullae, KP (-), anterior chamber shallow, peripheral anterior chamber <1/3 CT, aqueous flare (+), pupil round with a diameter of approximately 4mm, reactive to light (+), lens turbid, fundus not visible.",
        "DifferentialDiagnosis": "1. Acute iridocyclitis: Sudden onset of eye redness, eye pain, varying degrees of vision loss, intraocular pressure usually not elevated, significant anterior chamber inflammatory reaction, pupil constricted and irregular in shape.\n2. Glaucomatocyclitic crisis: Patients are mostly young and middle-aged adults, acute sharp increase in intraocular pressure, local irritation symptoms are mild, anterior chamber is not shallow, open angle, mutton-fat KPs on the posterior cornea."
    },
    "llm_answer_type": "LLM_HypotheticalRAG_Response",
    "temperature": 0
}